Events

December 2018

January 2019

February 2019

May 2019

December 2018

Cures Acceleration Network Review Board Meeting

Dec. 14, 2018

Webinar

This meeting of the Cures Acceleration Network Review Board will feature presentations by NCATS leadership and invited guests. NCATS staff will present proposed initiative concepts for CAN Review Board consideration.

Agenda (PDF - 287KB) • Federal Register Notice WebEx Registration

January 2019

NCATS Advisory Council and CAN Review Board Meeting

Jan. 10, 2019
8:30 a.m. to 4 p.m. ET

Webinar

The NCATS Advisory Council and Cures Acceleration Network Review Board will convene a joint virtual meeting at 8:30 a.m. The meeting will feature presentations by NCATS leadership and invited guests. NCATS staff will present proposed initiative concepts for Advisory Council/CAN Review Board consideration. For more information about the Advisory Council and CAN Review Board, visit the NCATS Advisory Council page and the Cures Acceleration Network Review Board page of this site.

February 2019

The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies Symposium

Feb. 7-8, 2019

NIH Campus
Natcher Conference Center (Building 45), Main Auditorium
Bethesda, Maryland

This National Center for Advancing Translational Sciences (NCATS)-sponsored The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies Symposium will highlight challenges and opportunities throughout the discovery and development process for addiction- and pain-related medications in the pre-competitive preclinical stage and provide a framework for more focused efforts within the research community.

Symposium Goals

  1. Identify next generation targets and pathways for pain and addiction treatment.
  2. Highlight lessons learned from successes and failures with current pain and addiction targets.
  3. Discuss biomarkers to enable clinical trials.
  4. Describe more predictive in vitro, in vivo and ex vivo assays for pain and addiction to validate new targets, pathways and clinical candidates and to address safety and efficacy.
  5. Examine new discovery technologies and methodologies for pain and addiction therapeutics (including small molecules and biologics).
  6. Highlight key NIH resources and initiatives to support the development of pain and addiction therapeutics.

WebsiteRegistrationAgenda (PDF - 135KB)

Rare Disease Day at NIH

Feb. 28, 2019
8:30 a.m.-4:00 p.m. ET

Rare disease day 2019 logo

NIH Campus
Natcher Conference Center (Building 45), Main Auditorium
Bethesda, Maryland

Sponsored by NCATS and the NIH Clinical Center, Rare Disease Day at NIH will feature speakers, including NCATS Director Christopher P. Austin, M.D.; NIH Clinical Center CEO James K. Gilman, M.D.; and NCATS Office of Rare Diseases Research Director Anne R. Pariser, M.D.

The event will feature interactive panel discussions on collective research models for rare diseases, patient registries, rare cancer research initiatives, and "no disease left behind, no patient left behind." New this year will be a presentation of the first ever Zebbie award for the NCATS Rare Diseases are Not Rare! Challenge. Other highlights include posters and exhibits by rare disease groups and researchers as well as artwork, videos and NIH Clinical Center tours. Admission is free and open to the public. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans. Be sure to follow the event on social media using #RDDNIH.

May 2019

RE(ACT) Congress AMERICA — International Congress on Research of Rare and Orphan Diseases

May 8­–11, 2019

Sheraton Centre Toronto Hotel
123 Queen Street West
Toronto, Ontario M5H 2M9 Canada

The 2019 RE(ACT) Congress, co-hosted by NCATS, will bring together internationally recognized scientific leaders and experts, young scientists, and patients and patient organizations to present and discuss rare disease research. The 2019 Congress, which will be held in Toronto, is the fifth edition of the event and the first to take place in North America. The Congress’s overarching goal is to promote international scientific cooperation in rare disease research. Registration is required.

Website • Registration • Program